Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Obstet Gynecol. May 10, 2014; 3(2): 61-66
Published online May 10, 2014. doi: 10.5317/wjog.v3.i2.61
Ovulation induction in the gynecological cancer patient
Amr H Wahba, Hesham Al-Inany
Amr H Wahba, Hesham Al-Inany, Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, 11562 Cairo, Egypt
Author contributions: Wahba AH searched the literature and wrote the manuscript; Al-Inany H reviewed and edited the manuscript.
Correspondence to: Dr. Amr H Wahba, Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Kasr Al Ainy St., 11562 Cairo, Egypt. dr.amrwahba@yahoo.com
Telephone: +20-2-1002642285
Received: January 18, 2013
Revised: June 15, 2013
Accepted: June 18, 2013
Published online: May 10, 2014
Processing time: 478 Days and 23.5 Hours
Abstract

Malignancy is a serious disease that can lead to serious morbidity and mortality. However, the survival rates for women with cancers have increased significantly during the past decades, reflecting improved diagnosis and treatment. With the increased survival in young women with cancer, more attention is being paid to preservation of fertility, which is potentially jeopardized by chemotherapy and radiation therapy, aiming to limit the devastating sequelae of this serious illness by providing these young women with a hope for motherhood. In vitro fertilization with oocyte or embryo cryopreservation has emerged as an astounding method to preserve fertility. It entails induction of ovulation to produce oocytes, the number and quality of which are imperative factors predicting the potential efficacy of the fertility preservation procedure. The aim of this review is to discuss ovarian stimulation for fertility preservation in women with gynecological cancer.

Keywords: Ovulation induction; Ovarian stimulation; Gynecological cancer

Core tip: Malignancy is a serious illness that is potentially life threatening. However, the survival rates for women with cancers have increased significantly during the past decade, reflecting improved diagnosis and treatment. The aim of this review is to discuss options for ovarian stimulation for fertility preservation in women with gynecological cancer.